Quipt poised to ‘uplist’
By HME News Staff
Updated 9:45 AM CDT, Wed May 3, 2023
CINCINNATI – Quipt Home Medical has received conditional approval from the Toronto Stock Exchange to graduate its listing from the TSX Venture Exchange to the TSX. “Graduating to the Toronto Stock Exchange is a significant accomplishment, and I want to thank all our team members and shareholders for their ongoing support,” said Greg Crawford, chairman and CEO. “Our ability to up-list demonstrates the evolution of our organization through the years and the ongoing momentum across the business in real time as we strive to become a national leader in respiratory care throughout the United States.” Final approval of the listing is subject to the company meeting certain customary conditions required by the TSX. Shareholders are not required to exchange their share certificates or take any other action in connection with the TSX listing, as there will be no change in the trading symbol or CUSIP for the common shares. Quipt will continue to trade its common shares on the NASDAQ in the United States under the symbol QIPT.
Comments